Octagon Capital Advisors LP 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:46 pm Unchanged | 2025-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Octagon Capital Advisors LP | 1,000,000 5.700% | 0 (Unchanged) | Filing |
| 2025-08-12 4:05 pm Purchase | 2025-06-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Octagon Capital Advisors LP | 1,000,000 7.800% | 1,000,000 (New Position) | Filing |